MM
Michael Patrick Miller
Director

Michael Patrick Miller insider trades: Puma Biotechnology (PBYI) stock sales

Director, Puma Biotechnology Last trade Nov 11, 2025 93 Form 4 filings
$97K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
56
Open-market trades
since 2005
6
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

56 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 11, 2025PBYI↓ Sell$97K
Aug 12, 2024PBYI↓ Sell$81K
Nov 7, 2023PBYI↓ Sell$71K
Jun 13, 2023PBYI↓ Sell$47K
Aug 9, 2022PBYI↓ Sell$89K
Mar 16, 2022PBYI↓ Sell$72K
Mar 12, 2020JAZZ↓ Sell$153K
Feb 13, 2020JAZZ↓ Sell$213K
Jan 13, 2020JAZZ↓ Sell$220K
Dec 9, 2019JAZZ↓ Sell$224K
Nov 13, 2018JAZZ↓ Sell$30K
Oct 12, 2018JAZZ↓ Sell$32K
Sep 14, 2018JAZZ↓ Sell$33K
Aug 14, 2018JAZZ↓ Sell$35K
Jul 13, 2018JAZZ↓ Sell$36K
Jun 14, 2018JAZZ↓ Sell$35K
May 14, 2018JAZZ↓ Sell$33K
Apr 13, 2018JAZZ↓ Sell$31K
Mar 14, 2018JAZZ↓ Sell$30K
Feb 14, 2018JAZZ↓ Sell$28K
Jan 12, 2018JAZZ↓ Sell$30K
Dec 11, 2017JAZZ↓ Sell$28K
Aug 15, 2017JAZZ↓ Sell$29K
Jul 17, 2017JAZZ↓ Sell$31K
Jun 15, 2017JAZZ↓ Sell$30K
May 15, 2017JAZZ↓ Sell$31K
Apr 17, 2017JAZZ↓ Sell$31K
Mar 15, 2017JAZZ↓ Sell$28K
Feb 15, 2017JAZZ↓ Sell$27K
Jan 17, 2017JAZZ↓ Sell$23K
Dec 15, 2016JAZZ↓ Sell$21K
Nov 15, 2016JAZZ↓ Sell$22K
Oct 17, 2016JAZZ↓ Sell$24K
Sep 19, 2016JAZZ↓ Sell$25K
Aug 15, 2016JAZZ↓ Sell$14K
Jul 15, 2016JAZZ↓ Sell$14K
Jun 15, 2016JAZZ↓ Sell$15K
May 16, 2016JAZZ↓ Sell$15K
Apr 15, 2016JAZZ↓ Sell$15K
Mar 15, 2016JAZZ↓ Sell$13K
Feb 16, 2016JAZZ↓ Sell$12K
Jan 15, 2016JAZZ↓ Sell$12K
Dec 15, 2015JAZZ↓ Sell$14K
Nov 16, 2015JAZZ↓ Sell$13K
Oct 15, 2015JAZZ↓ Sell$13K
Sep 25, 2015JAZZ↓ Sell$15K
Jul 18, 2012VVUS↓ Sell$759K
Jun 27, 2012VVUS↓ Sell$702K
Jun 12, 2012VVUS↓ Sell$625K
Nov 1, 2005CNCT↓ Sell10b5-1$65K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PBYI insiders

Open-market trades in the last 12 months

About Michael Patrick Miller's insider trades

Michael Patrick Miller is a director at Puma Biotechnology (PBYI). Since May 2, 2005, Michael has reported no open-market purchases and 56 sales worth $4.9M on SEC Form 4. In the last 12 months: 1 sale ($97K).

7 sales (13% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (26 filings), shares withheld for taxes (14 filings), option exercises (10 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBYI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.